Stockscreener 앱 받기
1.37
6.20%
0.08
시간 외 거래:
1.35
-0.02
-1.46%
Standard Biotools Inc 주식(LAB)의 최신 뉴스
With 48% stake, Standard BioTools Inc. (NASDAQ:LAB) seems to have captured institutional investors' interest - Yahoo
Deeper Dive: Understanding Standard BioTools Inc (LAB) Through its Various Ratios - DWinneX
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Raises Stock Holdings in Standard BioTools Inc. (NASDAQ:LAB) - MarketBeat
Standard BioTools Inc. (NASDAQ:LAB) Shares Bought by Bank of America Corp DE - Defense World
Standard BioTools Inc. (NASDAQ:LAB) Shares Sold by California State Teachers Retirement System - Defense World
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $970,000 Stock Position in Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools Inc. (NASDAQ:LAB) Shares Sold by Two Sigma Investments LP - Defense World
Standard BioTools Inc. (NASDAQ:LAB) Stake Cut by Nuveen Asset Management LLC - Defense World
Standard BioTools: Too Early To Determine The Fate Of This Turnaround (NASDAQ:LAB) - Seeking Alpha
ProShare Advisors LLC Buys 27,334 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
BNP Paribas Financial Markets Decreases Stake in Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Insider Selling: Standard BioTools Inc. (NASDAQ:LAB) SVP Sells 13,217 Shares of Stock - MarketBeat
Jane Street Group LLC Has $414,000 Holdings in Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools to Host Inaugural “Proteomics Roundtable” Webc - GuruFocus
Standard BioTools (LAB) Unveils Proteomics Roundtable Series | L - GuruFocus
Standard BioTools (LAB) Unveils Proteomics Roundtable Series | LAB Stock News - GuruFocus
Deutsche Bank AG Increases Holdings in Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools to Host Inaugural 'Proteomics Roundtable” Webcast Series - The Manila Times
Standard BioTools to Host Inaugural “Proteomics Roundtable” Webcast Series - GlobeNewswire
Standard BioTools to host inaugural ‘Proteomics Roundtable’ series - TipRanks
Top Executive Sells Thousands of Standard BioTools Shares! - TipRanks
Standard biotools CEO Michael Egholm sells $5,150 in stock By Investing.com - Investing.com Canada
Standard biotools CEO Michael Egholm sells $5,150 in stock - Investing.com
Standard biotools CEO Michael Egholm sells $5,126 in stock By Investing.com - Investing.com Canada
Standard biotools CEO Michael Egholm sells $5,126 in stock - Investing.com
Further weakness as Standard BioTools (NASDAQ:LAB) drops 15% this week, taking five-year losses to 79% - simplywall.st
Standard BioTools Inc. (NASDAQ:LAB) Stocks Pounded By 26% But Not Lagging Industry On Growth Or Pricing - simplywall.st
Standard biotools executive sells $25,784 in stock By Investing.com - Investing.com South Africa
Standard biotools executive sells $25,784 in stock - Investing.com India
Standard Biotools CEO Michael Egholm sells shares worth $4,860 - Investing.com Australia
Standard Biotools CEO Michael Egholm sells shares worth $4,860 By Investing.com - Investing.com India
Fluidigm stock plunges to 52-week low of $0.95 - Investing.com Australia
Fluidigm stock plunges to 52-week low of $0.95 By Investing.com - Investing.com Canada
Northern Trust Corp Has $5.03 Million Stock Position in Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools Inc. (NASDAQ:LAB) Shares Sold by Dimensional Fund Advisors LP - Defense World
Price T Rowe Associates Inc. MD Buys 16,475 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference - MarketScreener
Standard BioTools outlines $165M-$175M revenue target for FY2025 while driving proteomics partnerships - MSN
Before You Sell Standard BioTools Inc (NASDAQ: LAB) Shares, Here’sWhat You Need To Know. - Stocksregister
Standard BioTools First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
MetLife Investment Management LLC Purchases 40,057 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools Inc. Earnings Call: Mixed Outlook Amid Challenges - TipRanks
Standard BioTools Inc. (NASDAQ:LAB) Q1 2025 Earnings Call Transcript - Insider Monkey
Standard BioTools Inc (LAB) Q1 2025 Earnings Call Highlights: Navigating Challenges with ... - Yahoo
Standard BioTools Inc (LAB) Q1 2025 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
0.54%
1.82%
자본화:
|
볼륨(24시간):